A clinical trial to test the effect of emotion regulation based intervention in patients with depressio
- Conditions
- Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
- Registration Number
- CTRI/2024/07/070358
- Lead Sponsor
- Kezia Iris Christopher
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Individuals with a principle diagnosis of moderate to severe depression, single episode and recurrent according to the DSM V criteria with or without other comorbid Axis I diagnosis or Axis II traits as assessed and screened by DIAMOND and SCID-V PD.
2. Patients who are fluent and conversant in English or Tamil, with an ability to read English.
3. Patients whose symptoms are stabilized with medication for at least 4 weeks.
4. Patients willing to commit to 3-4 months of therapy.
1. Patients with other Axis I or II primary diagnosis, other neurological, neurodevelopmental disorders or any other organic cause that can affect engagement in therapy.
2. Individuals having depression with psychotic symptoms.
3. Patients who have substance use disorder, with immediate need for detox.
4. Patients who are already in therapy and have had over 5 sessions in the past 3 months.
5. Patients with high suicidality or those whose symptoms interfere in the therapy process as assessed clinically during intake or screening.
6. Women who are pregnant or meet criteria for post-partum depression.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity in Depression ScoresTimepoint: Baseline <br/ ><br>Post Intervention <br/ ><br>3-month followup
- Secondary Outcome Measures
Name Time Method Severity of Anxiety <br/ ><br>Severity of Depression(Self-report) <br/ ><br>Emotion Regulation <br/ ><br>Distress Tolerance <br/ ><br>Experiential Avoidance <br/ ><br>Affect <br/ ><br>Beliefs <br/ ><br>Cognitive Flexibility <br/ ><br>Working AllianceTimepoint: Baseline <br/ ><br>Mid-Intervention <br/ ><br>Post Intervention <br/ ><br>3-month Followup